| JVLIX | RMFEX | JVLIX / RMFEX | |
| Total Expense Ratio | 0.71 | 0.62 | 115% |
| Annual Report Gross Expense Ratio | 0.72 | 0.62 | 116% |
| Fund Existence | 30 years | 24 years | - |
| Gain YTD | 18.285 | 9.694 | 189% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250000 | 250 | 100,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 19.5B | 118B | 17% |
| Annual Yield % from dividends | 0.69 | 1.41 | 49% |
| Returns for 1 year | 21.81 | 9.45 | 231% |
| Returns for 3 years | 32.55 | 34.42 | 95% |
| Returns for 5 years | 20.65 | 39.25 | 53% |
| Returns for 10 years | 77.53 | 100.56 | 77% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| HNVRX | 54.96 | 0.41 | +0.75% |
| Harbor Small Cap Value Retirement | |||
| DESGX | 29.05 | 0.10 | +0.35% |
| DWS Enhanced Core Equity Institutional | |||
| ALMRX | 29.61 | 0.07 | +0.24% |
| Alger Mid Cap Growth Institutional I | |||
| IAXIX | 11.21 | -0.03 | -0.27% |
| VY® T. Rowe Price Divers Mid Cap Gr I | |||
| PRHSX | 89.67 | -1.08 | -1.19% |
| T. Rowe Price Health Sciences | |||